SOPH - SOPHiA GENETICS S.A.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.50
DETAILS
HIGH:
$8.00
LOW:
$7.00
MEDIAN:
$7.50
CONSENSUS:
$7.50
UPSIDE:
32.74%
About SOPHiA GENETICS S.A. (https://www.sophiagenetics.com)
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Jurgi Camblong | Co-Founder, CEO & Executive Chairman | 1979 | $1,208,481 USD |
| Abhimanyu Verma | EVP & Chief Technology Officer | – | – |
| Daan van Well | Executive VP and Chief Legal & Compliance Officer | 1975 | – |
| George A. Cardoza | Executive Vice President & Chief Financial Officer | 1962 | – |
| Kellen Sanger | Head of Strategy and Investor Relations | – | – |
| Kevin Puylaert | SVP & Chief Sales Officer | – | – |
| Manuela Da Silva Valente | Executive Vice President & Chief People Officer | 1971 | – |
| Philippe Menu | Executive Vice President, Chief Medical Officer & Chief Product Officer | 1982 | – |
| Ross Jordan Muken | President & Director | 1981 | – |
| Zhenyu Xu | Executive Vice President & Chief Scientific Officer | 1983 | – |